Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Transplant Cell Ther. 2023 Mar 14;29(6):367–374. doi: 10.1016/j.jtct.2023.03.010

Table 2A:

Multivariable analysis: predictors of frailty (CGVHD severity included, no organs)

Variable Class OR (95% CI) p-value Global p-value

CGVHD severity None/Mild Reference <.001
Moderate 1.6 (0.8, 3.2) 0.17
Severe 3.6 (1.7, 7.3) <.001
Thrombocytopenia Platelets >=100,000/mm3 Reference
Platelets <100,000/mm3 2.0 (1.1, 3.4) 0.02
Age at enrollment (years) <40y Reference 0.008
40–55y 1.2 (0.6, 2.3) 0.66
>55y 2.2 (1.1, 4.4) 0.02

Abbreviations: CGVHD, chronic graft-versus-host disease